ADT vs ESAB

ADT's Advanced Deterministic Scorecard reveals a mixed profile: the Piotroski F-Score of 4/9 indicates borderline financial health, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite solid profitability metrics—such as a 25.65% operating margin and 17.24% ROE—concerns persist due to weak liquidity (Current Ratio: 0.67, Quick Ratio: 0.37) and high leverage (Debt/Equity: 2.16). The stock trades below the analyst target price of $9.48 and near the Graham Number of $8.48, suggesting modest value, but growth is moderate and insider sentiment is neutral. Technical trend is bearish, and recent price performance shows weakness over the past six months despite a strong 1-year earnings surprise record.

ESAB exhibits strong operational health with a Piotroski F-Score of 7/9 and a healthy balance sheet (Debt/Equity 0.61), yet it faces a significant valuation disconnect. While the company has a remarkable track record of beating earnings estimates for 16 consecutive quarters, the current price of $101.28 trades at a substantial premium to its Graham Number ($57.36) and Intrinsic Value ($28.70). The outlook is conflicted: analysts maintain a 'strong_buy' with a target of $136.56, but technical trends are bearish (0/100) and YoY earnings growth has plummeted by 31.6%.